Literature DB >> 14711554

Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.

Lisa Farah-Eways1, Rosario Reyna, Eric S Knochenhauer, Alfred A Bartolucci, Ricardo Azziz.   

Abstract

OBJECTIVE: To determine if insulin or glucose action plays a role in adrenocortical steroidogenesis in the polycystic ovary syndrome (PCOS).
DESIGN: Prospective cohort study.
SETTING: Academic medical center. PATIENT(S): Nine reproductive-aged patients with PCOS and nine age-, race-, and body mass index-matched controls. MAIN OUTCOME MEASURE(S): Insulin-modified frequently sampled intravenous glucose tolerance testing and an acute 60-minute ACTH-(1-24) stimulation test. From the glucose tolerance test, glucose and insulin were measured and the insulin sensitivity index, glucose effectiveness, and acute insulin response to glucose were determined. Dehydroepiandrosterone sulfate (DHEAS) basally and 17-hydroxypregnenolone, 17-hydroxyprogesterone, DHEA, androstenedione, and cortisol during ACTH testing at 0 and 60 minute (steroid(0) and steroid(60)) were determined. The net change in steroid during the ACTH test was calculated. RESULT(S): The insulin sensitivity index had limited correlation with adrenocortical variables in both groups. In patients with PCOS, glucose effectiveness was positively associated with DHEAS, cortisol(0), cortisol(60), change in cortisol, DHEA(0), DHEA(60), change in DHEA, 17-hydroxyprenenolone(60), change in 17-hydroxypregnenolone, DHEA(0), androstenedione(0), 17-hydroxyprenenolone(0), 17-hydroxyprogesterone(0), 17-hydroxyprenenolone(60), and 17-hydroxyprogesterone(60). CONCLUSION(S): Adrenocortical biosynthesis, basally and in response to ACTH, appears to be closely associated with glucose effectiveness in PCOS. A common factor determining both the effectiveness of glucose to control its own production or uptake and adrenocortical biosynthesis may be aberrant in PCOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711554     DOI: 10.1016/j.fertnstert.2003.05.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Authors:  Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Maheswari Thangavelu; Usha Rani Godla
Journal:  J Assist Reprod Genet       Date:  2013-06-22       Impact factor: 3.412

2.  Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Ricardo Azziz
Journal:  Hum Reprod       Date:  2014-05-09       Impact factor: 6.918

3.  Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Damini Dey; Daniel Berman; Ida Y Chen; Daniel A Dumesic; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

4.  In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.

Authors:  Dumindra Gurusinghe; Sharan Gill; Rogelio U Almario; Jennifer Lee; William F Horn; Nancy L Keim; Kyoungmi Kim; Sidika E Karakas
Journal:  Fertil Steril       Date:  2009-04-01       Impact factor: 7.329

5.  Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.

Authors:  Kathleen Brennan; Andy Huang; Ricardo Azziz
Journal:  Fertil Steril       Date:  2008-04-25       Impact factor: 7.329

Review 6.  The adrenal and polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Ricardo Azziz
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

7.  Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women.

Authors:  Sebastião Freitas de Medeiros; Cinthia Marenza Ormond; Matheus Antônio Souto de Medeiros; Nayara de Souza Santos; Camila Regis Banhara; Márcia Marly Winck Yamamoto
Journal:  Endocr Connect       Date:  2017-08-07       Impact factor: 3.335

8.  Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome.

Authors:  Nese Cinar; Ayla Harmanci; Duygu Yazgan Aksoy; Kadriye Aydin; Bulent Okan Yildiz
Journal:  J Ovarian Res       Date:  2012-12-07       Impact factor: 4.234

9.  Increased Adrenal Androgens in Overweight Peripubertal Girls.

Authors:  Christine M Burt Solorzano; Kristin D Helm; James T Patrie; Rana F Shayya; Heidi L Cook-Andersen; R Jeffrey Chang; Christopher R McCartney; John C Marshall
Journal:  J Endocr Soc       Date:  2017-04-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.